THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

Ballentine Partners, LLC's Holding History (CIK: 0001374889)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 14,362 Value ($000) $269 Avg Close $16.59 Range $13.50 - $20.33

Q3 2025

Shares 14,388 Value ($000) $210 Avg Close $12.64 Range $10.82 - $14.87

Q2 2025

Shares 14,315 Value ($000) $158 Avg Close $9.72 Range $7.90 - $11.82

Q1 2025

Shares 13,094 Value ($000) $117 Avg Close $9.31 Range $8.35 - $10.90

Q4 2024

Shares 13,094 Value ($000) $123 Avg Close $9.10 Range $7.88 - $10.26

Q3 2024

Shares 12,848 Value ($000) $104 Avg Close $8.66 Range $7.44 - $10.42

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	14,362	$269	$16.59	$13.50 - $20.33
Q3 2025	14,388	$210	$12.64	$10.82 - $14.87
Q2 2025	14,315	$158	$9.72	$7.90 - $11.82
Q1 2025	13,094	$117	$9.31	$8.35 - $10.90
Q4 2024	13,094	$123	$9.10	$7.88 - $10.26
Q3 2024	12,848	$104	$8.66	$7.44 - $10.42